✦ LIBER ✦

26 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 3. Results of a randomised trial evaluating palliation & quality of life

✍ Scribed by Billingham, L.J.; Cullen, M.H.; Woods, J.; Chetiyawardana, A.D.; Joshi, R.C.; Cook, J.; Woodroffe, C.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

11 Mitomycin, ifosfamide and cisplatin (

✍ Cullen, M.H.; Woodroffe, C.M.; Billingham, L.J.; Chetiyawardana, A.D.; Joshi, R. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 125 KB

10 Mitomycin, ifosfamide and cisplatin (

✍ Cullen, M.H.; Billingham, L.J.; Woodroffe, C.M.; Gower, N.; Souhami, R.L.; Cheti 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 125 KB

A phase II/III randomised comparison of

✍ Rudd, R.M; Gower, N.H; James, L.E; Gregory, W; Eisen, T.Q; Lee, S.M; Harper, P.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

8 Mitomycin, ifosfamide and cisplatin (M

✍ Cullen, M.H.; Billingham, L.J.; Dunn, J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Combination of cisplatin, ifosfamide and

✍ Barón, FJ; Ceuva, JF; Vázquez, F; Candamio, S; Calvo, M; Menéndez, MD; Irigoyen, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 252 KB

A randomised clinical trial of vindesine

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 148 KB